1. Treatment of calcium nephrolithiasis in the patient with hyperuricosuria

   • Omotayo Arowojolu
   • David S. Goldfarb

   Review 01 April 2014 Pages: 601 - 605

   

2. Osteoprotegerin and kidney disease

   • Alejandra Montañez-Barragán
   • Isaias Gómez-Barrera
   • Alberto Ortiz

   Review 23 April 2014 Pages: 607 - 617

   

3. Dealing with stuck hemodialysis catheter: state of the art and tips for the nephrologist

   • Giacomo Forneris
   • Daniele Savio
   • Dario Roccatello

   Review 16 October 2014 Pages: 619 - 625

   

4. Angiotensin II type 1 receptor blockade ameliorates proteinuria in puromycin aminonucleoside nephropathy by inhibiting the reduction of NEPH1 and nephrin

   • Aya Takahashi
   • Yoshiyasu Fukusumi
   • Hiroshi Kawachi

   Original Article 09 October 2014 Pages: 627 - 634

   

5. A longitudinal assessment of the natural rate of decline in renal function with age

   • Eytan Cohen
   • Yuval Nardi
   • Ilan Krause

   Original Article 19 March 2014 Pages: 635 - 641

   

6. Independent or synergistic relationship of proteinuria and glomerular filtration rate on patient and renal survival in patients with glomerulonephritis?

   • Dominik G. Haider
   • Salome Masghati
   • Walter H. Hörl

   Original Article 08 March 2014 Pages: 643 - 651

   

7. Prevalence of hyperuricemia among Chinese adults: a national cross-sectional survey using multistage, stratified sampling

   • Hong Liu
   • Xiao-Min Zhang
   • Bi-Cheng Liu

   Original Article 01 April 2014 Pages: 653 - 658

   

8. Drug–drug interactions between sucroferric oxyhydroxide and losartan, furosemide, omeprazole, digoxin and warfarin in healthy subjects

   • Edward Chong
   • Veena Kalia
   • Peter Winkle

   Original Article Open access 04 April 2014 Pages: 659 - 666

9. SIX1 gene: absence of mutations in children with isolated congenital anomalies of kidney and urinary tract

   • Susanna Negrisolo
   • Sonia Centi
   • Lina Artifoni

   Original Article 05 June 2014 Pages: 667 - 671

   

10. Adherence to phosphate binders in hemodialysis patients: prevalence and determinants

    • Yoleen P. M. Van Camp
    • Bernard Vrijens
    • Monique M. Elseviers

    Original Article 22 February 2014 Pages: 673 - 679

    

11. Administration of IL-1ra improves adiponectin levels in chronic hemodialysis patients

    • Adriana M. Hung
    • Chutatip Limkunakul
    • Talat Alp Ikizler

    Original Article 08 March 2014 Pages: 681 - 688

    

12. Management of mineral metabolism in hemodialysis patients: discrepancy between interventions and perceived causes of failure

    • Pasquale Esposito
    • Teresa Rampino
    • IAMM Group

    Original Article 08 May 2014 Pages: 689 - 697

    

13. l-Carnitine status in end-stage renal disease patients on automated peritoneal dialysis

    • Lorenzo Di Liberato
    • Arduino Arduini
    • Mario Bonomini

    Original Article 06 March 2014 Pages: 699 - 706

    

14. Proton-pump inhibitors do not influence serum magnesium levels in renal transplant recipients

    • Charlotte Van Ende
    • Steven Van Laecke
    • Michel Jadoul

    Original Article 10 May 2014 Pages: 707 - 711

15. Single-side renal sympathetic denervation to treat malignant refractory hypertension in a solitary kidney patient

    • Flavio Ribichini
    • Angela Ferrara
    • Corrado Vassanelli

    Case Report 11 February 2014 Pages: 713 - 716

    

16. Erratum to: Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study

    • Matteo Ruggeri
    • Antonio Bellasi
    • Biagio Di Iorio

    Erratum 07 August 2014 Pages: 717 - 717